Leveraged, Inverse, and Commodity ETFs

Not suitable for all investors, these ETFs or other exchange traded products represent unique risks, including leverage, derivatives, and complex investment strategies. Learn more

DB Base Metals Double Long ETN
Change company Symbol lookup
Select an option...
BDDXF DB Base Metals Double Long ETN
BURL Burlington Stores Inc
TNEN True North Energy Corp
H Hyatt Hotels Corp
ACEL Accel Entertainment Inc
USLM United States Lime & Minerals Inc
BWEN Broadwind Inc
EQIX Equinix Inc
TXMD TherapeuticsMD Inc
ORC Orchid Island Capital Inc
Go


Based in United Kingdom
Company profile

Closing Price
$9.00
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
0

Karuna Therapeutics to Present at Upcoming Investor Conferences

6:30 am ET June 6, 2022 (BusinessWire) Print

Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will present at the following upcoming investor conferences:

William Blair 42nd Annual Growth Stock Conference Date: Wednesday, June 8, 2022 Time: 5:00 p.m. ET

Goldman Sachs 43rd Annual Global Healthcare Conference Date: Tuesday, June 14, 2022 Time: 5:00 p.m. ET

A live webcast of the presentations will be available on the Investor Relations page of Karuna's website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna's website following the conference.

About Karuna Therapeutics

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives. For more information, please visit www.karunatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005094/en/

SOURCE: Karuna Therapeutics, Inc.

Investor: 
Alexis Smith
518-338-8990
asmith@karunatx.com 

Media: 
Lauren Sneider
917-886-0247
lsneider@karunatx.com
comtex tracking

COMTEX_408273337/1006/2022-06-06T06:30:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.